|
LIN37 expression based on
|
Statistics: Unpaired two sample T-test was employed to evaluate levels of significance in expression level between any two sample groups
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.340400E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.368800E-01 |
| Normal-vs-Stage2 |
7.380400E-01 |
| Normal-vs-Stage3 |
7.203800E-01 |
| Normal-vs-Stage4 |
9.384200E-01 |
| Stage1-vs-Stage2 |
6.009000E-01 |
| Stage1-vs-Stage3 |
8.214800E-01 |
| Stage1-vs-Stage4 |
9.270600E-01 |
| Stage2-vs-Stage3 |
5.337200E-01 |
| Stage2-vs-Stage4 |
7.224000E-01 |
| Stage3-vs-Stage4 |
8.339200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.668200E-01 |
| Normal-vs-AfricanAmerican |
3.918200E-01 |
| Normal-vs-Asian |
9.828400E-02 |
| Caucasian-vs-AfricanAmerican |
5.005800E-01 |
| Caucasian-vs-Asian |
3.068400E-02 |
| AfricanAmerican-vs-Asian |
5.811600E-02 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.198200E-01 |
| Normal-vs-Female |
6.125800E-01 |
| Male-vs-Female |
2.435200E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.977400E-01 |
| Normal-vs-Age(41-60Yrs) |
9.116400E-01 |
| Normal-vs-Age(61-80Yrs) |
4.584000E-01 |
| Normal-vs-Age(81-100Yrs) |
5.639400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.838400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.642200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.481400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.442400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.492000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.728600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
8.828300E-04 |
| Classical-VS-Follicular |
3.140200E-01 |
| Classical-VS-Other |
8.050000E-01 |
| Classical-VS-Normal |
8.434800E-01 |
| Tall-VS-Follicular |
8.995200E-04 |
| Tall-VS-Other |
2.281400E-01 |
| Tall-VS-Normal |
6.544500E-03 |
| Follicular-VS-Other |
9.079600E-01 |
| Follicular-VS-Normal |
4.866200E-01 |
| Other-VS-Normal |
8.363000E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.118400E-01 |
| Normal-vs-N1 |
8.086400E-01 |
| N0-vs-N1 |
7.092200E-01 |
|
|
